HC Wainwright & Co. Reiterates Buy on Rockwell Medical, Maintains $20 Price Target

Benzinga Newsdesk www.benzinga.com Neutral 88.0%

Neg 0% Neu 88% Pos 0%

HC Wainwright & Co. analyst Raghuram Selvaraju reiterates Rockwell Medical (NASDAQ:RMTI) with a Buy and maintains $20 price target.